Ely Benaim has an estimated net worth of $5.77 Million. This is based on reported shares across multiple companies, which include NovoCure Ltd, and REXAHN PHARMACEUTICALS, INC..

2021 was Ely Benaim's most active year for acquiring shares with 10 total transactions. Ely Benaim's most active month to acquire stocks was the month of February. 2021 was Ely Benaim's most active year for disposing of shares, totalling 20 transactions. Ely Benaim's most active month to dispose stocks was the month of April. 2022 saw Ely Benaim paying a total of $2,907,710.30 for 53,522 shares, this is the most they've acquired in one year. In 2021 Ely Benaim cashed out on 37,511 shares for a total of $4,084,595.61, their largest year based on trade value.